14 November 2018 - Rep. Frank Pallone Jr., who is slated to be the next chairman of a House committee overseeing drug prices, said Wednesday that his top priorities on the issue are allowing Medicare to negotiate prices and speeding the approval of cheaper generic drugs.

Pallone, who is set to become chairman of the House Energy and Commerce Committee in January, pointed to President Trump’s support for those two policies in expressing hope for a bipartisan deal.

“I've always been an advocate for negotiated prices under Medicare, and as you know, President Trump says that he's for that, so I think that’s an area where we can get agreement with the president,” Pallone told reporters.

Read The Hill article